ZOLL Itamar logo — Home Sleep Apnea Test and Digital Health Company.

ZOLL Itamar

Home Sleep Apnea Test and Digital Health Company.

Founded 1997 United States Atlanta, United States 310 employees Post Ipo Secondary Total: $351.55M Health Care, Medical Devices

General Information

Company Name ZOLL Itamar
Founded Year 1997
Location United States Atlanta, United States +3
Employees 310
Industries Health Care, Medical Devices
Funding Stage Post Ipo Secondary
Social

Get notified when ZOLL Itamar moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About ZOLL Itamar

ZOLL Itamar is a healthcare startup that has been revolutionizing the integration of Sleep Apnea management into the cardiac patient care pathway since its founding in 1997. Based in the United States, the company has established itself as a pioneer in home sleep testing, offering innovative solutions for patients and healthcare professionals. Its most recent $70.00M Post-IPO Secondary investment at 07 February 2021 was secured from Cybele Holdings. ZOLL Itamar's commitment to digital health and medtech is evident in its impactful home sleep apnea test program. This noteworthy investment testifies to the company's potential for significant growth and its attractiveness to discerning investors seeking opportunities in the sleep and cardiology sectors. For more information, visit the company's website and disclaimer at https://bit.ly/3dZfGPU. With a strong focus on innovation and its track record as an industry leader, ZOLL Itamar is poised for continued success in the evolving landscape of telehealth and medical technology.

Taxonomy: Sleep Apnea, Digital Health, Cardiology, Medtech, Telehealth, Home Sleep Test, Respiratory Disorders, Cardiovascular Disease, Non-Invasive, Endothelial Dysfunction, Arterial Health, Obstructive Sleep Apnea, Hypertension, Sleep Disorders

Funding Rounds & Investors (12)

View All
Funding Stage Amount Investors Lead Investors Date
Post-IPO Secondary •••••• 1 •••• •••• 07 Feb 2021
Post-IPO Secondary •••••• - 02 Feb 2020
Post-IPO Equity •••••• 4
Investor Investor Investor
•••• ••••
18 Jan 2019
Venture Round •••••• 1 •••• •••• 01 Mar 2018
Venture Round •••••• 1 •••• •••• 01 Dec 2015

View All 12 Funding Rounds

ZOLL Itamar Alternatives & Competitors

ZOLL Itamar vs
Invicta Medical
Invicta Medical United States

Millions of people suffer from sleep apnea every single night. We will not rest until they sleep pea...

Non Equity Assistance
13 employees
Health Care, Health and Wellness
ZOLL Itamar vs
Bairitone Health
Bairitone Health United States

Learn what really happens during sleep.

Non Equity Assistance
4 employees
Health Care, Health and Wellness
ZOLL Itamar vs

Fatigue and Sleep Apnea diagnostics and management solutions, in the community and within the occupa...

13 employees
Health Care, Health and Wellness
Also compare with: ZOLL Itamar vs The Snore Shop The Snore Shop

FAQ About ZOLL Itamar

Home Sleep Apnea Test and Digital Health Company.
ZOLL Itamar was founded in 1997.
ZOLL Itamar is headquartered in Atlanta, United States.
ZOLL Itamar operates in the following industries: Health Care, Medical Devices.
ZOLL Itamar has approximately 310 employees.
ZOLL Itamar has completed 12 funding rounds, raising a total of $351.55M. The latest funding stage is Post Ipo Secondary.
Top alternatives and competitors to ZOLL Itamar include Invicta Medical, Bairitone Health, Rebel Sleep Institute Inc., SleepQuest, The Snore Shop. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ZOLL Itamar and Invicta Medical are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors ZOLL Itamar and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

One analytics cookie (Google Analytics). Cookie Policy